[go: up one dir, main page]

CY1763A - Suppository comprising a calcitonin and taurocholic acid or a salt thereof - Google Patents

Suppository comprising a calcitonin and taurocholic acid or a salt thereof Download PDF

Info

Publication number
CY1763A
CY1763A CY176394A CY176394A CY1763A CY 1763 A CY1763 A CY 1763A CY 176394 A CY176394 A CY 176394A CY 176394 A CY176394 A CY 176394A CY 1763 A CY1763 A CY 1763A
Authority
CY
Cyprus
Prior art keywords
suppository
calcitonin
taurocholic acid
salt
suppositories
Prior art date
Application number
CY176394A
Other languages
English (en)
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721700A external-priority patent/GB8721700D0/en
Priority claimed from GB888801991A external-priority patent/GB8801991D0/en
Priority claimed from GB888805068A external-priority patent/GB8805068D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of CY1763A publication Critical patent/CY1763A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
CY176394A 1987-09-15 1994-07-15 Suppository comprising a calcitonin and taurocholic acid or a salt thereof CY1763A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878721700A GB8721700D0 (en) 1987-09-15 1987-09-15 Organic compounds
GB888801991A GB8801991D0 (en) 1988-01-29 1988-01-29 Improvements in/relating to organic compounds
GB888805068A GB8805068D0 (en) 1988-03-03 1988-03-03 Improvements in/relating to organic compounds

Publications (1)

Publication Number Publication Date
CY1763A true CY1763A (en) 1994-07-15

Family

ID=27263605

Family Applications (1)

Application Number Title Priority Date Filing Date
CY176394A CY1763A (en) 1987-09-15 1994-07-15 Suppository comprising a calcitonin and taurocholic acid or a salt thereof

Country Status (26)

Country Link
US (1) US5149537A (no)
JP (1) JPH01228919A (no)
KR (1) KR970003052B1 (no)
AT (1) AT396424B (no)
AU (1) AU614769B2 (no)
BE (1) BE1001937A3 (no)
CA (1) CA1330417C (no)
CH (1) CH677320A5 (no)
CY (1) CY1763A (no)
DE (1) DE3830245A1 (no)
DK (1) DK509888A (no)
ES (1) ES2012119A6 (no)
FI (1) FI87889C (no)
FR (1) FR2620331B1 (no)
GB (1) GB2209670B (no)
HK (1) HK19394A (no)
HU (1) HU203204B (no)
IL (1) IL87747A (no)
LU (1) LU87334A1 (no)
MY (1) MY103611A (no)
NL (1) NL8802274A (no)
NO (1) NO175518C (no)
NZ (1) NZ226162A (no)
PH (1) PH24766A (no)
PT (1) PT88491B (no)
SE (1) SE8803222L (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013601A1 (en) * 1990-03-15 1991-09-19 Rhône-Poulenc Rorer International (Holdings) Inc. Calcitonin suppository formulations
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
DE69924740T2 (de) 1998-07-24 2005-09-01 Yoo, Seo Hong Klare wässrige lösungen enthaltend gallensäuren
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
CN100558407C (zh) * 2000-02-04 2009-11-11 柳署弘 制备含有胆汁酸的澄清水溶液剂型
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
PL2316473T3 (pl) 2003-07-23 2014-05-30 Novartis Ag Zastosowanie kalcytoniny w chorobie zwyrodnieniowej stawów
EP1789057B1 (en) * 2004-08-30 2010-02-24 Seo Hong Yoo Neuroprotective effect of solubilized udca in focal ischemic model
AU2005295541B2 (en) * 2004-10-15 2011-02-17 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
CA2585471A1 (en) * 2004-11-01 2006-05-11 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
US8143314B1 (en) 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
KR102287352B1 (ko) * 2015-06-30 2021-08-06 (주)아모레퍼시픽 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH211204A (de) * 1938-12-13 1940-08-31 Chem Ind Basel Verfahren zur Herstellung einer Suppositoriengrundmasse.
US4164573A (en) * 1975-06-13 1979-08-14 Galinsky Alvin M Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
ATE8584T1 (de) * 1980-01-16 1984-08-15 Hans Georg Prof. Dr. Weder Verfahren und dialysiereinrichtung zur herstellung von bilayer-vesikeln und verwendung der bilayer-vesikel.
JPS56118013A (en) * 1980-02-25 1981-09-16 Teijin Ltd Calcitonin pharmaceutical and its preparation
JPS56138110A (en) * 1980-03-28 1981-10-28 Teijin Ltd Suppository containing citric acid or salt thereof
JPS56138115A (en) * 1980-03-31 1981-10-28 Teijin Ltd Suppository containing acidic amino acid or derivative thereof
DE3171774D1 (en) * 1980-03-31 1985-09-19 Teijin Ltd Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina

Also Published As

Publication number Publication date
HK19394A (en) 1994-03-18
FI884191L (fi) 1989-03-16
FR2620331B1 (fr) 1991-11-08
GB2209670B (en) 1991-05-08
NO884053D0 (no) 1988-09-13
AT396424B (de) 1993-09-27
JPH01228919A (ja) 1989-09-12
NO175518C (no) 1994-10-26
FI87889C (fi) 1993-03-10
GB2209670A (en) 1989-05-24
DK509888D0 (da) 1988-09-13
SE8803222D0 (sv) 1988-09-13
SE8803222L (sv) 1989-03-16
PT88491A (pt) 1988-10-01
HUT47864A (en) 1989-04-28
KR890004680A (ko) 1989-05-09
AU614769B2 (en) 1991-09-12
CH677320A5 (no) 1991-05-15
DK509888A (da) 1989-03-16
LU87334A1 (fr) 1989-07-07
HU203204B (en) 1991-06-28
NO175518B (no) 1994-07-18
PT88491B (pt) 1992-11-30
KR970003052B1 (ko) 1997-03-14
NZ226162A (en) 1991-03-26
ATA224788A (de) 1993-01-15
MY103611A (en) 1993-08-28
GB8821429D0 (en) 1988-10-12
FI884191A0 (fi) 1988-09-13
BE1001937A3 (fr) 1990-04-17
ES2012119A6 (es) 1990-03-01
US5149537A (en) 1992-09-22
AU2217588A (en) 1989-04-20
CA1330417C (en) 1994-06-28
FI87889B (fi) 1992-11-30
PH24766A (en) 1990-10-01
DE3830245A1 (de) 1989-03-30
FR2620331A1 (fr) 1989-03-17
IL87747A0 (en) 1989-02-28
NL8802274A (nl) 1989-04-03
NO884053L (no) 1989-03-16
IL87747A (en) 1992-05-25

Similar Documents

Publication Publication Date Title
US5149537A (en) Use of taurocholic acid and its salts as enhancers for calcitonin containing pharmaceutical compositions
EP0424954B1 (en) Pharmaceutical composition for treatment of osteoporosis
US5719122A (en) Pharmaceutical compositions containing a calcitonin
EP0332222B1 (en) Intravaginal delivery of biologically active polypeptides
US5183802A (en) Pharmaceutical compositions for intranasal administration of calcitonin
EP0404490A1 (en) Fast dissolving dosage forms
US6337090B1 (en) Orally administrable solid ribavirin dosage forms and process for making them
CA1299495C (en) Pharmaceutical composition containing polypeptide
US5441933A (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
JP2002501015A (ja) リーシュマニア症の治療における経口投与のためのミルテフォシンを含有する固形医薬品
US20030211983A1 (en) Pharmaceutical preparations comprising cyclosporin for oral administration
IE48133B1 (en) A sold stable pharmaceutical composition based on 17 -ethynyl-1,3-dibenzoyloxy-7 -methyl-1,3,5(10)-oestratien-17 -ol
GB2257908A (en) Peptide compositions
CH669909A5 (no)
JPH02503314A (ja) ヒトの異常脂肪血症治療剤
JP2939403B2 (ja) プロラクチン又は成長ホルモンの分泌促進剤
JPH1087482A (ja) 解熱鎮痛剤